Found: 13
Select item for more details and to access through your institution.
Association of Serum Dupilumab Levels at 16 Weeks With Treatment Response and Adverse Effects in Patients With Atopic Dermatitis: A Prospective Clinical Cohort Study From the BioDay Registry.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Association of Serum Ustekinumab Levels With Clinical Response in Psoriasis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Optimization of a Quantitative Anti-Drug Antibodies against Infliximab Assay with the Liquid Chromatography-Tandem Mass Spectrometry: A Method Validation Study and Future Perspectives.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 5, p. 1477, doi. 10.3390/pharmaceutics15051477
- By:
- Publication type:
- Article
Therapeutic Drug Monitoring of Vedolizumab in Inflammatory Bowel Disease Patients during Maintenance Treatment—TUMMY Study.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 3, p. 972, doi. 10.3390/pharmaceutics15030972
- By:
- Publication type:
- Article
Fingerprick blood samples to measure serum natalizumab concentrations.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 3, p. 457, doi. 10.1177/13524585221136448
- By:
- Publication type:
- Article
Immunogenicity of TNF-Inhibitors.
- Published in:
- Frontiers in Immunology, 2020, p. 1, doi. 10.3389/fimmu.2020.00312
- By:
- Publication type:
- Article
Comprehensive evaluation of microneedle‐based intradermal adalimumab delivery vs. subcutaneous administration: results of a randomized controlled clinical trial.
- Published in:
- British Journal of Clinical Pharmacology, 2021, v. 87, n. 8, p. 3162, doi. 10.1111/bcp.14729
- By:
- Publication type:
- Article
Ocrelizumab Concentration Is a Good Predictor of SARS‐CoV‐2 Vaccination Response in Patients with Multiple Sclerosis.
- Published in:
- Annals of Neurology, 2023, v. 93, n. 1, p. 103, doi. 10.1002/ana.26534
- By:
- Publication type:
- Article
Loss of the GPI‐anchor in B‐lymphoblastic leukemia by epigenetic downregulation of PIGH expression.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 1, p. 93, doi. 10.1002/ajh.25337
- By:
- Publication type:
- Article
Dynamics of antibodies to SARS‐CoV‐2 in convalescent plasma donors.
- Published in:
- Clinical & Translational Immunology, 2021, v. 10, n. 5, p. 1, doi. 10.1002/cti2.1285
- By:
- Publication type:
- Article
Using Real‐World Data to Guide Ustekinumab Dosing Strategies for Psoriasis: A Prospective Pharmacokinetic‐Pharmacodynamic Study.
- Published in:
- CTS: Clinical & Translational Science, 2020, v. 13, n. 2, p. 400, doi. 10.1111/cts.12725
- By:
- Publication type:
- Article
Patient‐centered dupilumab dosing regimen leads to successful dose reduction in persistently controlled atopic dermatitis.
- Published in:
- Allergy, 2022, v. 77, n. 11, p. 3398, doi. 10.1111/all.15439
- By:
- Publication type:
- Article
Case report: Pharmacokinetics of pembrolizumab in a patient with stage IV non-small cell lung cancer after a single 200 mg administration.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2022.960116
- By:
- Publication type:
- Article